相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Usefulness of lymphocyte-to-monocyte, neutrophil-to-monocyte and neutrophil-to-lymphocyte ratios as prognostic markers in breast cancer patients treated with neoadjuvant chemotherapy
C. Marin Hernandez et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2018)
The preoperative neutrophil to lymphocyte ratio is a superior indicator of prognosis compared with other inflammatory biomarkers in resectable colorectal cancer
Yongxi Song et al.
BMC CANCER (2017)
Association of neutrophil/lymphocyte ratio and platelet/lymphocyte ratio with ER and PR in breast cancer patients and their changes after neoadjuvant chemotherapy
J. Xu et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2017)
Pretreatment neutrophil-to-lymphocyte ratio is correlated with response to neoadjuvant chemotherapy as an independent prognostic indicator in breast cancer patients: a retrospective study
Yi Chen et al.
BMC CANCER (2016)
Cancer treatment and survivorship statistics, 2016
Kimberly D. Miller et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
Neutrophils in the Tumor Microenvironment
Davalyn R. Powell et al.
TRENDS IN IMMUNOLOGY (2016)
Pre-treatment neutrophil to lymphocyte ratio may be a useful tool in predicting survival in early triple negative breast cancer patients
Mirco Pistelli et al.
BMC CANCER (2015)
Preoperative lymphocyte-monocyte and platelet-lymphocyte ratios as predictors of overall survival in patients with bladder cancer undergoing radical cystectomy
Gui-Ming Zhang et al.
TUMOR BIOLOGY (2015)
Contrasting breast cancer molecular subtypes across serial tumor progression stages: biological and prognostic implications
Siker Kimbung et al.
ONCOTARGET (2015)
The Neutrophil to Lymphocyte Ratio has a High Negative Predictive Value for Pathologic Complete Response in Locally Advanced Breast Cancer Patients Receiving Neoadjuvant Chemotherapy
Melek Karakurt Eryilmaz et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2014)
Cancer and systemic inflammation: treat the tumour and treat the host
C. S. D. Roxburgh et al.
BRITISH JOURNAL OF CANCER (2014)
Use of [18F]-FDG PET to predict response to neoadjuvant trastuzumab and docetaxel in patients with HER2-positive breast cancer, and addition of bevacizumab to neoadjuvant trastuzumab and docetaxel in [18F]-FDG PET-predicted non-responders (AVATAXHER): an open-label, randomised phase 2 trial
Bruno Coudert et al.
LANCET ONCOLOGY (2014)
A central review of histopathology reports after breast cancer neoadjuvant chemotherapy in the neo-tango trial
E. Provenzano et al.
BRITISH JOURNAL OF CANCER (2013)
Detailed analysis of inflammatory cell infiltration in colorectal cancer
J. P. Vayrynen et al.
BRITISH JOURNAL OF CANCER (2013)
Optimization of the systemic inflammation-based Glasgow Prognostic Score
Michael J. Proctor et al.
CANCER (2013)
Tumor-associated macrophages as potential diagnostic and prognostic biomarkers in breast cancer
Xiaoqiang Tang
CANCER LETTERS (2013)
Usefulness of Pretreatment Neutrophil to Lymphocyte Ratio in Predicting Disease-Specific Survival in Breast Cancer Patients
Hany Noh et al.
JOURNAL OF BREAST CANCER (2013)
Prognostic and Predictive Value of Tumor-Infiltrating Lymphocytes in a Phase III Randomized Adjuvant Breast Cancer Trial in Node-Positive Breast Cancer Comparing the Addition of Docetaxel to Doxorubicin With Doxorubicin-Based Chemotherapy: BIG 02-98
Sherene Loi et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Pretreatment neutrophil/lymphocyte ratio is superior to platelet/lymphocyte ratio as a predictor of long-term mortality in breast cancer patients
Basem Azab et al.
MEDICAL ONCOLOGY (2013)
Modulation of neutrophil granulocytes in the tumor microenvironment: Mechanisms and consequences for tumor progression
Claudia A. Dumitru et al.
SEMINARS IN CANCER BIOLOGY (2013)
Early prediction of pathologic response to neoadjuvant therapy in breast cancer: Systematic review of the accuracy of MRI
M. L. Marinovich et al.
BREAST (2012)
Predictive Biomarkers in Breast Cancer: Their Value in Neoadjuvant Chemotherapy
L. Fuksa et al.
CANCER INVESTIGATION (2012)
Eosinophil Count and Neutrophil-Lymphocyte Count Ratio as Prognostic Markers in Patients with Bacteremia: A Retrospective Cohort Study
Roser Terradas et al.
PLOS ONE (2012)
Cancer-related inflammation: Common themes and therapeutic opportunities
Frances R. Balkwill et al.
SEMINARS IN CANCER BIOLOGY (2012)
Strategies for subtypes-dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011
A. Goldhirsch et al.
ANNALS OF ONCOLOGY (2011)
Molecular Anatomy of Breast Cancer Stroma and Its Prognostic Value in Estrogen Receptor-Positive and -Negative Cancers
Giampaolo Bianchini et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Clinical trial update: implications and management of residual disease after neoadjuvant therapy for breast cancer
Erica L. Mayer et al.
BREAST CANCER RESEARCH (2007)
Progress in human tumour immunology and immunotherapy
SA Rosenberg
NATURE (2001)
分享论文
